Replies to post #75313 on Innovation Pharmaceuticals Inc (IPIX)

[loanranger]

"The primary outcome measure is not statistically tied to D."

It seems to be to me (and others). Unless I don't understand what you mean by "primary outcome".

From the PR:
"All three Brilacidin treatment arms (two single-dose regimens and one three-day dose regimen) reached the primary endpoint, with the clinical success rate for each dosing regimen statistically comparable to the clinical success rate of the FDA-approved seven-day dosing regimen of daptomycin."

"All we know is B met the primary endpoint and was the statistical equal of Daptomycin at that point. "
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=107540933